4DMedical Limited
MQ7.F
2.14 EUR
1 Tag: 0.0% (0.00 EUR)
Der Alarm wird direkt gespeichert, ohne auf die Homepage zu springen.
Kursalarme fuer MQ7.F
Bitte anmelden, um Kursalarme zu sehen und zu speichern.
Finanzen
Unternehmensinfo
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.
Aktuelle News
-
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
Vorschau anzeigen
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through June 19th. Please Schedule 1x1 Meetings here. The presentations will be available 24/7 for 90 days. Investors, advisors, and ana
-
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
Vorschau anzeigen
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.comNEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run th
-
AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
Vorschau anzeigen
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced presentations from the April 23rd AI & Technology Virtual Investor Conference are available for on-demand viewing. Investors, advisors, and analysts can now access presentations at their convenience. REGISTER AND VIEW PRESENTATIONS HERE The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor ma
-
AI & Technology Virtual Investor Conference Agenda Announced for April 23rd
Vorschau anzeigen
Company executives will discuss their business strategies, provide updates on recent developments, and answer questions live at VirtualInvestorConferences.comNEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the AI & Technology Virtual Investor Conference to be held April 23rd, 2026. The event will feature presentations from senior executives of companies operating across the artificial in
-
4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
Vorschau anzeigen
4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading "CT:VQ™" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging.